chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blood clots in lungs, legs and brain; She cant speak or stand on her own/in diaper; This spontaneous case was reported by a non-health professional (subsequently medically confirmed) and describes the occurrence of THROMBOSIS (Blood clots in lungs, legs and brain) and PHYSICAL DISABILITY (She cant speak or stand on her own/in diaper) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048A21A and 022M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced THROMBOSIS (Blood clots in lungs, legs and brain) (seriousness criteria hospitalization prolonged and medically significant) and PHYSICAL DISABILITY (She cant speak or stand on her own/in diaper) (seriousness criterion hospitalization prolonged). The patient was treated with HEPARIN (intravenous) at a dose of UNK dosage form. At the time of the report, THROMBOSIS (Blood clots in lungs, legs and brain) and PHYSICAL DISABILITY (She cant speak or stand on her own/in diaper) outcome was unknown.            Concomitant medications were not provided. Reporter stated that hospital is trying to send the patient to a nursing home. No further treatment information was not provided.  Company Comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
pt recv vax 20OCT95 & exp pain in rt shoulder, & had diff elevating arm;sx persisted for 30 days;pt given Medrol dosepak & dx w/brachial plexopathy;pt cont to exp numbness & weakness in rt arm;
Complained of dizziness and feeling like she will pass out. Client in back of Jeep lying down with feet elevated. 11:35am client states less dizzy and sitting up drinking soda. 12:01 vital signs stable; ambulating well, color pink, denied dizziness, pruritus. Left site in stable condition.
Right upper arm cellulitis and low grade fever. Benadryl for a  few nights. Keflex 250 mg/5mL.
This spontaneous report was received from a nurse practitioner regarding unspecified number of patients whose demographics were unknown. The medical history of patients and their concurrent conditions were not reported. On an unknown date in 2015 (also reported as unspecified dates starting on or after 06-NOV-2015) unspecified number patients were vaccinated with unspecified number of improperly stored doses of (Oka/Merck) VARIVAX (lot/batch # L023594, expiry date 26-JUN-2017; lot/batch # L029469, expiry date 06-AUG-2017, lot/batch # L032395, 26-AUG-2017) dose, route unknown. Concomitant medications were not reported. No adverse effects were reported. Product quality complaint (PQC) was not filed. This is one of the two reports reported by the same reporter. Additional information has been requested.
Fever - Information has been received from a physician concerning a 16 year old female, who was vaccinated with measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live second generation lot # not available while living in another country and developed a fever post - immunization.  The date of the immunization was unknown.  The physician reported that information was very limited an in Spanish.  No futher information is available.
Information has been received from a licensed practical nurse concerning a female patient in her 20's who was vaccinated with a dose of Gardasil and experienced mild soreness at the injection site after the vaccination was given. The same source reported that another had the same reaction (WAES # 0705USA00565). Additional information has been requested.
Patient had mild itching 15 minutes post vaccine administration. Benadryl was administered and patient was monitored. No further adverse reactions.
Patient started feeling nauseous and was feeling very faint. He did state that he ate before coming to get vaccinated.
Shortly after receiving the Janssen vaccine, Patient began feeling  "a rush going down her body, dizziness, and felt the medicine in her arm." She became pale and diaphoretic. She rested 30 minutes, attempted to stand to transfer to a wheelchair, felt dizzy again. She laid down again for approximately 10 minutes and slowly sat up and stated she was "feeling better. Patient's father picked her up and drove her home.
Dizziness, Headache, Myalgia, Arthralgia,  Numbness at upper lip and pruritus all over the body Narrative: The above reported symptoms lasted longer than usual although the symptoms are improving. She still have some itching, fatigue, and lethargy on the 11th day of post vaccination.
103 degree fever and chills; pain in the left side of jaw, pain and difficulty when walking. Treatment: 1600mg of Ibuprofen...I am still experiencing pain in my left jaw, especially when I am eating.
This spontaneous report as received from a Medical Assistant who administers vaccines refers to a currently 18 year old female patient with not pertinent Medical history or Drug reactions/allergies. On 25-JAN-2013, the patient was vaccinated intramuscularly with the first and only dose of GARDASIL lot # 0324AE, Expire date: 20-OCT-2014 (dose not reported). No concomitant medications reported. The medical assistant noted the patient stated that on the same day (25-JAN-2013) she "experienced swelling in both hands as well as hives on an unspecified part of her body." The outcome of the events was unknown. No treatment was given to the patient. No lab tests were performed. The patient sought Medical Attention by calling the office about that. The causal assessment was not provided by the reporter. Additional information has been requested.
The night of vaccine unable to sleep due to fever and body aches. Continued fever and body aches the next day May 22. Started to feel better May 23, but still not quite right. Felt completely back to normal Monday, May 24. Sunday May 30 I started have itchy blisters on elbows and hands. This has spread to 70 % of my body and they are now painful and blood filled.
15 mins after first COVID-19 shot, pt developed CP, left arm numbness and tingling. denies sob.
Splotchy Redness and extreme itching on both left and right arms, hands and feet started itching about an hour later. Took 1 dose of benedryl and redness subsided.
This is a spontaneous report from contactable consumer (Pfizer employee) who reported for her mother. A 67-year-old female patient received PREVNAR 13, via an unspecified route of administration at single dose in the upper arm on an unspecified date in 2014. The patient medical history and concomitant medications were not reported. 2-3 hours after the administration of the vaccines, the patient could not move her arm forward to backward further mentioned that it was so sore and painful that she could not move her arm forward and backward. The patient had not taken any medication in response to the adverse event and further mentioned that she was fine. Follow-up (23Jan2015): Follow-up attempts completed. No further information expected.
11/21 Admitted due to car crash, lab test positive for detection of COVID-19 virus. Asymptomatic.
Report # 200103753-1 described seizure-like activity in a two month old female who received Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine adsorbed (Infanrix) for prevention of Diphtheria, Tetanus, and Pertussis. The vaccinee had no known allergies or medical history. There was no illness at the time of vaccination. The vaccinee was delivered via a normal vaginal delivery at 38 weeks gestational age. On 06/04/01 at 17:30, the vaccinee received her 1st left thigh dose of Infanrix, in addition to a left thigh dose of Haemophilus B Conjugate  (meningococcal protien conjugate) and Hepatitis B (recombinant) vaccine (Comvax, Merck) and a left thigh dose of inactivated Poliovirus vaccine (IPV) Aventis Pasteur). Three hours later, On 06/04/01 at 20:30, per the other, the vaccinee experienced "seizure-like" activity with staring and jerking movements; the infant was "sleepy-tired". The vaccinee was not blue per the reporter and was afebrile at this time. The vaccinee was transported to the hospital on 06/04/01 at 20:30  and was admitted. She had a fever at the time of admission to the hospital. She currently was still hospitalized. Unspecified treatment was performed on 06/06/01 (no results as of yet).  As of 06/06/01, the vaccinee was still hospitalized.  Follow up on 07/09/2001: "Febrile seizure.  The vaccine provider has submitted this report directly to vaers.  Jerking/shaking movements.  She was not responsive to voice.  On the way to the hospital, the infant had a "dusky spell".  On arrival at the hospital, she was described as "normal, healthy alert infant".  She was hospitalized for observation.  She had a fever of as much as 102 degrees F two hours after admission.   On 06/05/2001, the results were interpreted as normal.  The diagnosis was febrile seizure.  The vaccinee recovered without treatment was discharged from the hospital on 06/06/2001.  The reporter stated that the febrile seizure was moderate in intensity and was possibly related to Infanrix.  As of 07/02/2001, there were "no further problems at present."
Per father, pt diagnosed with bilateral cellulitis in arms on 12/9/10. Per father - both arms were red and warm to touch.
After the 3rd dose, I had a positive ANA test. I started getting weird results on my blood test and my white blood cells were off. They thought I had a UTI, but I didn't. I continue to have an elevated white blood cell count to this day. I got my menstrual cycle after this vaccine for a week and it went away. I haven't had it since.
Fever, extreme fatigue on the next day after the vaccination. Resolved on October 1st
Patient fainted within 5 minutes after receiving the Janssen vaccine. He then appeared to be experiencing a seizure lasting no more than a minute.  No history of fainting or seizure. EMS was called and arrived within about 10 minutes, and patient appeared to experience another seizure and he vomited. EMS then transported the patient to the hospital.
This medically confirmed spontaneous report (initial receipt 17-Nov-2015) concerns an 18 month-old infant patient. On an unspecified date, the patient received Afluria injection (Influenza virus vaccine polyvalent, batch number not provided) 0.5 mL once via the intramuscular route for the protection against seasonal influenza in the infant. The child patient received a 'double paediatric dose' of 0.5mL of Afluria. On an unspecified date, approximately after a week, the patient experienced a fever, was cranky and had an ear infection. The outcome was unknown. Reporter's Comments: Reporter's comments: The reporter reported the terms 'overdose' and 'off label use', and reported that the fever was possibly due to Afluria or concomitant ear infection. Sender's Comments: Company comments: Seriousness criterion/criteria: Medically significant. Listedness: Unlisted. Assessment according to the CCDS for CSL Inactivated Influenza Virus vaccine and the Afluria PI, ear infection is unlisted. Fever and feeling cranky (irritability) are listed are listed. Overdose, medication error and product administered to child of inappropriate age are also unlisted.  Causality: Unrelated. Time to onset is approximately 1 week following vaccination. Fever following CSL IVV in a child generally occurs within hours/ same days and unlikely after 72 hours. In this case the ear infection which is not uncommon in children under 5 was the probable cause of fever and irritability. Causality for other events (overdose, medication error and product administered to child of inappropriate age) is unassessable.
Mild itching, mild discomfort, and rash in 2" oval area surrounding site of injection
I tested positive for Covid-19 on March 22, 2023 I experienced nasal congestion, loss of taste, loss of smell, runny nose, sneezing, coughing, low grade fever for about 3 days. I was prescribed PAXLOVID for my symptoms on March 22. I tested negative on March 30, 2023 and my symptoms came back on March 31 I started testing positive again. I finally tested negative on April 7, 2023.
Excessive crying x 5 hours, jerking, no fever, call mother for further information.
Rash, on the left side of my body, neck, both sides, and face. Looks similar to a heat rash on body and neck, looks like a sunburn on my face.
Rash on left arm by injection site.   Itchy and warm feeling.  However, I have no temperature feeling on the left side, so I am not sure how it "feels warm".
Received injections at approx. 9:30 AM, and during early evening the patient developed redness and mild swelling at injection sites.  On 08/14/2013 upon wakening the patient's mother noticed "her back was fire engine red."
Approx. 5 hours after shot broke out in a profuse sweat, got dizzy and passed out while standing in my kitchen.  Felt unstable for about an hour after then symptoms subsided.  No other reactions after that
This spontaneous report was received from a physician via a company representative, referring to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 16-JUN-2015, the patient was vaccinated with an improperly stored dose of GARDASIL "10x1 sdv" which had a lot number of K007828 and expiration date on 02-MAR-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified date, the GARDASIL vaccine had two temperature excursions; one for 712 hours with lowest recorded temperature of 33 F (0.555555556 Celsius) and other one for 216 hours and lowest recorded temperature of 32 F (o Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has ben requested.
PAIN AT INJECTION SITE WHEN TOUCHED; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 180522, and batch number: 180522 expiry: UNKNOWN) .5 ml, administered on 12-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 12-MAR-2021, the subject experienced pain at injection site when touched. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of pain at injection site when touched was not reported. This report was non-serious.
Mom reported rash began on 3FEB91 became worse 4FEB91. Seen by MD dx w/as erythemia multiforme; temp 99, child looks awful & feels miserable from rash.
Arm swelled up, (double size) was very red, redness as far as wrist. Has blisters inside mouth (roof of mouth) 3 separate times over 2 weeks. Seeing doctor for this.
04/30/19--patient reports "not feeling well: in the afternoon around 16:00. 17:30 reports symptoms of shaking and chills. 22:00 reports feeling fevered, did not take temperature. 5/1/19 patient woke up around 7:00am and had a headache and neck pain that were resolved with over-the-counter ibuprofen. She informed her primary care provider of her symptoms and was offered an appointment that day, 5/1/19 however denied need for appointment. Later in the day the patient reports redness and warmth at the site, left deltoid. She did not have any shortness of breath or feelings of throat closing at any time. 5/6/19 reports to office and all symptoms have resolved.
On the 8/16/2014 in the evening my daughter broke out with about 10 chicken pox on her arms and legs.  Then on 08/20/2014 in the evening developed a fever that reached 102.6 F. She still has a fever, however today it is around 100.5 F.  She has no other symptoms of sickness.
following initial vaccine 12/28, got extremely bloated with joint tightness, fluid overload, inflammation, overall discomfort, back pain which radiated to the front of the chest lasting x3 days, took Tylenol. now resolved
Threw up; Severe headache; Chills; Body aches; Temperature is at 101; Arm started hurting; Really tired; A report was received from a consumer concerning a 54 year old male patient who was participating in the mRNA-1273 trial and developed upper arm pain, headache, feeling tired, fever, chills, body aches, and vomiting.     The patient's medical history, as provided by the reporter, included COVID-19.  No relevant concomitant medications were reported.   On 05 Jan 2021, approximately two hours prior to the onset of the events, the patient received his first of two planned doses of mRNA-1273 intramuscularly in his upper left arm for prophylaxis of COVID-19 infection.   The patient's arm started hurting on 05 Jan 2021.  On 06 Jan 2021 the patient experienced a severe headache, a temperature of 101 degrees Fahrenheit, chills, and body aches.  On 07 Jan 2021 the patient vomited and his fever continued.  He treated the events with Tylenol, and ibuprofen, and an ice pack.  Action taken with mRNA-1273 in response to the events was not provided .   The outcome of the events headache, fever, feeling tired, chills, body aches, and vomiting were not reported. The event upper arm pain was recovering.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Face is puffy; One single red splash in the left leg, it was about an 1 1/2 inch in diameter and it was sensitive; One single red splash in the left leg and it was sensitive; Little bit itchy; Felt a little funny; Little shaky; Unwell; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Face is puffy), PRURITUS (Little bit itchy), FEELING ABNORMAL (Felt a little funny), TREMOR (Little shaky) and MALAISE (Unwell) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045J21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Clot blood (taking blood thinner). Concurrent medical conditions included Immunocompromised (taking immunosuppressant medication). Concomitant products included PREDNISONE for an unknown indication.    On 22-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In December 2021, the patient experienced PRURITUS (Little bit itchy), FEELING ABNORMAL (Felt a little funny), TREMOR (Little shaky) and MALAISE (Unwell). On 28-Dec-2021, the patient experienced ERYTHEMA (One single red splash in the left leg, it was about an 1 1/2 inch in diameter and it was sensitive) and SENSITIVE SKIN (One single red splash in the left leg and it was sensitive). On 29-Dec-2021, the patient experienced SWELLING FACE (Face is puffy). In December 2021, PRURITUS (Little bit itchy), FEELING ABNORMAL (Felt a little funny), TREMOR (Little shaky) and MALAISE (Unwell) had resolved. On 29-Dec-2021, ERYTHEMA (One single red splash in the left leg, it was about an 1 1/2 inch in diameter and it was sensitive) and SENSITIVE SKIN (One single red splash in the left leg and it was sensitive) had resolved. At the time of the report, SWELLING FACE (Face is puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient stated she was unaware of her biological date of birth. However, she provided her documented date of birth.  The patient was taking medications, which were not reported  She also had one single red splash in the left leg.  It was about an 1 1/2 inch in diameter. It was sensitive and lasted a day ad was taking antihistamine. She was schedule to receive the second dose.  Treatment medication was not provided by the reporter.
Knot in arm day after, then 2nd day after vaccination got very red, swollen and uncomfortable. Took about a week to go down.
Pt developed cellulitis to left upper arm closer to the Axilla. Pt had hx of radiation therapy to throat and lymph nodes (upper portion of body).
I awoke in morning and I was very weak and shaky and unable to walk. It was as if I had no balance at all. I had a flushed face,, hot,, and had temp high of 101°. It might have gotten higher but I don't remember,  but I really felt like I was gonna die,  .  It got worse by the hour. I contacted my Dr's office, and they said it was not unusual to have reaction to the vaccine.  They said if I still was like this next day to call then.  By nightfall the symptoms lessened and not feverish either.  I woke next morning fine. Little weak, but fine in all other areas described that first day.  I was told it was normal, so with that I never knew to report it.
Intense joint pain causing difficulty using both arms as well as difficulty walking due to hip joint pain.  Blood tests confirmed PMR and a steroid regimen (Prednisone) was initiated.  Initial dosage was 40mg/day titrated down to 10mg/day over a 30 day period.  Now taking 10mg/day and titrating down to 1mg/day by 12/31/2022.  Still have a limited range of motion in right arm.   In addition to prednisone, I am participating in water aerobics and physical therapy.  Doctors have advised PMR symptoms could persist for up to 3 years.
Chills; Fever; Headache; Muscle pain; Joint pain; This is a spontaneous report from a non-contactable consumer, the patient. A 69-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) via an unspecified route of administration in the right arm on 03Mar2021 (at the age of 69-year-old) at 09:45 and second dose of BNT162b2(PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: unknown) via an unspecified route of administration in the right arm on 24Mar2021 at 10:00 as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, high blood pressure (BP) The patient was allergic to penicillin and sulfonamide (Sulfa). Concomitant medications received within 2 weeks of the vaccination included unspecified daily prescription medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was diagnosed with COVID-19 on an unknown date. Since the vaccination, the patient had not tested positive for COVID-19. On 03Mar2021, after the first dose of vaccination, the patient experienced chills, fever, nausea, headache, muscle pain and joint pain. No therapeutic measures were taken for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events such as Chills, fever, nausea, headache, muscle pain and joint pain were recovered with lasting effects at the time of reporting.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Tinnitus beginning one day (1/20) after administration of second dose of COVID-19 vaccine.
Chicken pox appearing on trunk and, later, limbs, with itching but no fever.
Fever, chills, &  dizziness.  Blurry vision,  aches/pains and shortness of breath.
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose01/09/21 2nd dose02/06/21 Diagnosed covid positive:09/10/21 Symptom onset:09/08/21 Exposure:community Symptoms:cough, fatigue,sore throat,runny nose.
Within 4-6 hours of the flu shot, started with high fever, muscle soreness, blurred vision, headache and lung congestion.  It lasted a good part of 24 hours.